Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase‐1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis
Open Access
- 3 October 2006
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 20 (13) , 2387-2389
Abstract
Microsomal postaglandin (PG) E synthase (mPGES)‐1 is an inducible enzyme that acts downstream of cyclooxygenase (COX) and specifically catalyzes the conversion of prostaglandin (PG)H 2 to PGE 2 , most prominently in inflammatory conditions. Specific inhibitors of mPGES‐1 are not yet available, however, mice with genetic deletion of mPGES‐1 have been generated that have given insight into the specific role of mPGES‐1 in eicosanoid biosynthesis in vivo and in peritoneal macrophages. We created mouse embryo fibroblast (MEF) cell lines that would facilitate investigation of the effect of mPGES‐1 genetic deletion on prostanoid biosynthesis in fibroblast lineage cells and its subsequent effect on the expression of inducible NOS (iNOS) and nitrite biosynthesis using cells derived from mPGES‐1 wild‐type (WT), heterozygous (Het), and null mice. The results show that genetic deletion of mPGES‐1 results in a dramatic decrease in PGE 2 production in Het and null MEFs under basal conditions and after stimulation with interleukin (IL)‐1β, suggesting that mPGES‐1 is critically important for PGE 2 production. Furthermore, we show that mPGES‐1 gene deletion results in diversion of prostanoid production from PGE 2 to 6‐keto PGF 1 α (the stable metabolic product of PGI 2 ; prostacyclin) in a gene dose‐dependent manner in Het and null MEFs compared with their WT counterparts, suggesting a shunting phenomenon within the arachidonic acid (AA) metabolic pathway. In addition, we show that mPGES‐1 gene deletion and subsequent decrease in PGE 2 levels results in a differential induction profile of iNOS and nitrite levels (the stable breakdown product of nitric oxide (NO) in mPGES‐1 WT MEFs compared with null MEFs. These results provide important information regarding the therapeutic potential for pharmacologic inhibition of mPGES‐1 in inflammatory conditions.—Kapoor, M., Kojima, F., Qian, M., Yang, L., and Crofford, L. J. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase‐1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. FASEB J. 20, E1704 –E1715 (2006)Keywords
This publication has 47 references indexed in Scilit:
- Atorvastatin Reduces the Expression of Prostaglandin E2 Receptors in Human Carotid Atherosclerotic Plaques and Monocytic CellsJournal of Cardiovascular Pharmacology, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synoviumArthritis & Rheumatism, 2004
- Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib**The investigators had full access to the data and complete control over the design, conduct analysis, interpretation, and description of the study. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or in writing the report. The views expressed are those of the investigators alone.The American Journal of Cardiology, 2003
- Specific cyclooxygenase-2 inhibitors: what have we learned since they came into widespread clinical use?Current Opinion in Rheumatology, 2002
- Identification and Characterization of a Novel Type of Membrane-Associated Prostaglandin E SynthaseBiochemical and Biophysical Research Communications, 2002
- Endothelial function as a determinant of vascular function and structure: A new therapeutic targetThe American Journal of Cardiology, 1997
- Physiological and pathophysiological roles of nitric oxideMicrosurgery, 1994
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979